期刊文献+

载脂蛋白J与脑损伤的研究进展 被引量:2

Research advance of apolipoprotein J in brain injury
原文传递
导出
摘要 载脂蛋白J在脑损伤中发挥重要的神经保护功能,参与脑损伤修复,在损伤后不同时段,Apo J含量及定位均呈现规律性的波动,即时空动态性,因此,对脑损伤的治疗及法医病理学脑损伤时间推断具有重要意义,本文综述了近期Apo J相关研究进展。 Apolipoprotein J plays an important role in neuroprotection and neurological restoration after brain injury. It shows spatiotemporal dynamic expression at varying times after brain injury. Thus, it will be of great importance in the clinical treatment of brain injury, as well as in post-injury intervals estimation in forensic pathology. In this paper, we will review relevant research advance of it in brain injury.
出处 《中国法医学杂志》 CSCD 2017年第5期476-479,共4页 Chinese Journal of Forensic Medicine
基金 国家自然科学基金面上项目(81273336) 华中科技大学学科交叉重点项目(2016JCTD117) 国家重点研发计划诈伤诈病法医学鉴定技术研究(2016YFC0800701)
关键词 法医病理学 载脂蛋白J 脑损伤 神经保护 forensic pathology Apolipoprotein J brain injury neuroprotection
  • 相关文献

参考文献1

二级参考文献38

  • 1Coronary Heart Disease-Auses, Symptoms, Prevention. Southern Cross Healthcare Group, 2013. Available from: https://www.southerncross.co.nz/AboutTheGroup/HealthResources/MedicalLibrary/tabid/178/vw/1/ItemID/191/Coronary-heart-disease-causes-symptoms-prevention.aspx. [Last accessed on 2014 Nov 11].
  • 2Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age : Statistics from World Health Organisation and United Nations. Int J Cardiol 2013;168:934-45.
  • 3World Health Organization, Department of Health Statistics and Informatics in the Information, Evidence and Research Cluster. The Global Burden of Disease 2004 Update. Geneva: World Health Organization; 2004.
  • 4Duffy D, Rader DJ. Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport. Circulation 2006;113:1140-50.
  • 5Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res 2006;98:1352-64.
  • 6Riwanto M, Rohrer L, Roschitzki B, Besler C, Mocharla P, Mueller M, et al. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease : Role of high-density lipoprotein-proteome remodeling. Circulation 2013;127:891-904.
  • 7Koltai T. Clusterin : A key player in cancer chemoresistance and its inhibition. Onco Targets Ther 2014;7:447-56.
  • 8Bettuzzi S. Conclusions and perspectives. Adv Cancer Res 2009;105:133-50.
  • 9Baralla A, Sotgiu E, Deiana M, Pasella S, Pinna S, Mannu A, et al. Plasma clusterin and lipid profile: A link with aging and cardiovascular diseases in a population with a consistent number of centenarians. PLoS One 2015;10:e0128029.
  • 10Trougakos IP, Gonos ES. Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 2002;34:1430-48.

共引文献8

同被引文献16

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部